Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma
- J. A. Elliott; J. V. Reynolds Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma Front Oncol
Publication Category: Cancer
Gold nanoparticles and obese adipose tissue microenvironment in cancer treatment
-
N. Essa; F. O'Connell; A. Prina-Mello; J. O'Sullivan; S. Marcone
Gold nanoparticles and obese adipose tissue microenvironment in cancer treatment Cancer Lett
Extratumoral PD-1 blockade does not perpetuate obesity-associated inflammation in esophageal adenocarcinoma
-
K. C. Galvin; M. J. Conroy; S. L. Doyle; M. R. Dunne; R. Fahey; E. Foley; K. E. O'Sullivan; D. G. Doherty; J. G. Geoghegan; N. Ravi; C. O'Farrelly; J. V. Reynolds; J. Lysaght
Extratumoral PD-1 blockade does not perpetuate obesity-associated inflammation in esophageal adenocarcinoma Cancer Lett
Cancer, obesity and immunometabolism – Connecting the dots
-
L. Dyck; L. Lynch
Cancer, obesity and immunometabolism – Connecting the dots Cancer Lett
Correction: Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function
-
L. Dyck; H. Prendeville; M. Raverdeau; M. M. Wilk; R. M. Loftus; A. Douglas; J. McCormack; B. Moran; M. Wilkinson; E. L. Mills; M. Doughty; A. Fabre; H. Heneghan; C. LeRoux; A. Hogan; E. T. Chouchani; D. O'Shea; D. Brennan; L. Lynch
Correction: Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function J Exp Med
Visceral obesity with and without metabolic syndrome: incidence and clinical impact in esophageal adenocarcinoma treated with curative intent
- J. A. Elliott; N. E. Donlon; P. Beddy; C. L. Donohoe; S. L. Doyle; S. King; N. Ravi; J. V. Reynolds Visceral obesity with and without metabolic syndrome: incidence and clinical impact in esophageal adenocarcinoma treated with curative intent Dis Esophagus
Obesity and increased risk of esophageal adenocarcinoma
- J. A. Elliott; C. L. Donohoe; J. V. Reynolds Obesity and increased risk of esophageal adenocarcinoma Expert Rev Endocrinol Metab
Impact of visceral obesity and metabolic syndrome on the postoperative immune, inflammatory, and endocrine response following surgery for esophageal adenocarcinoma
- S. L. Doyle; A. M. Mongan; C. L. Donohoe; G. P. Pidgeon; M. Sherlock; J. V. Reynolds; J. Lysaght Impact of visceral obesity and metabolic syndrome on the postoperative immune, inflammatory, and endocrine response following surgery for esophageal adenocarcinoma Dis Esophagus
Establishing computed tomography-defined visceral fat area thresholds for use in obesity-related cancer research
-
S. L. Doyle; A. M. Bennett; C. L. Donohoe; A. M. Mongan; J. M. Howard; F. E. Lithander; G. P. Pidgeon; J. V. Reynolds; J. Lysaght
Establishing computed tomography-defined visceral fat area thresholds for use in obesity-related cancer research Nutr Res
IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity
-
S. L. Doyle; C. L. Donohoe; S. P. Finn; J. M. Howard; F. E. Lithander; J. V. Reynolds; G. P. Pidgeon; J. Lysaght
IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity Am J Gastroenterol